Initial Statement of Beneficial Ownership (3)
February 04 2021 - 12:41PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Kraft Andrew Q. |
2. Date of Event Requiring Statement (MM/DD/YYYY)
11/24/2020
|
3. Issuer Name and Ticker or Trading Symbol
theMaven, Inc. [MVEN]
|
(Last)
(First)
(Middle)
225 LIBERTY STREET, 27TH FLOOR |
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director _____ 10% Owner ___X___ Officer (give title below) _____ Other (specify below) Chief Operating Officer / |
(Street)
NEW YORK, NY 10281
(City)
(State)
(Zip)
| 5. If Amendment, Date Original Filed(MM/DD/YYYY)
| 6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security (Instr. 4) | 2. Date Exercisable and Expiration Date (MM/DD/YYYY) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) |
Date Exercisable | Expiration Date | Title | Amount or Number of Shares |
Option to purchase | 1/13/2019 | 12/13/2028 | Common Stock | 1000000 (1) | $0.35 | D | |
Option to purchase | 3/31/2019 | 12/13/2028 | Common Stock | 400000 (2) | $0.35 | D | |
Option to purchase | 12/18/2020 (4) | 4/10/2029 | Common Stock | 1354193 (3) | $0.46 | D | |
Explanation of Responses: |
(1) | Grant vests monthly over 36 months, with adjustment such that 750,000 shares were vested as of 4/21/20 (with continued monthly vesting thereafter) |
(2) | Fully vested as of Form 3 filing date. |
(3) | Grant vests 1/3 after first year. Balance monthly over next 2 years. |
(4) | The ability to exercise is subject to both: i) vesting conditions (3) and ii) the Issuer's stockholders approving a requisite increase in authorized shares of common stock, after the date the grant was issued, that would apply to this grant; such requisite increased was finalized as of December 18, 2020. |
Reporting Owners
|
Reporting Owner Name / Address | Relationships |
Director | 10% Owner | Officer | Other |
Kraft Andrew Q. 225 LIBERTY STREET, 27TH FLOOR NEW YORK, NY 10281 |
|
| Chief Operating Officer |
|
Signatures
|
/s/ Andrew Q. Kraft | | 2/4/2021 |
**Signature of Reporting Person | Date |